Hiroaki Masuzaki

17.3k total citations · 2 hit papers
243 papers, 12.8k citations indexed

About

Hiroaki Masuzaki is a scholar working on Physiology, Endocrine and Autonomic Systems and Epidemiology. According to data from OpenAlex, Hiroaki Masuzaki has authored 243 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Physiology, 55 papers in Endocrine and Autonomic Systems and 55 papers in Epidemiology. Recurrent topics in Hiroaki Masuzaki's work include Adipose Tissue and Metabolism (56 papers), Regulation of Appetite and Obesity (55 papers) and Adipokines, Inflammation, and Metabolic Diseases (36 papers). Hiroaki Masuzaki is often cited by papers focused on Adipose Tissue and Metabolism (56 papers), Regulation of Appetite and Obesity (55 papers) and Adipokines, Inflammation, and Metabolic Diseases (36 papers). Hiroaki Masuzaki collaborates with scholars based in Japan, United States and United Kingdom. Hiroaki Masuzaki's co-authors include Yoshihiro Ogawa, Kazuwa Nakao, Kiminori Hosoda, Jeffrey S. Flier, Jonathan R. Seckl, John J. Mullins, Nicholas M. Morton, Hiroshi Shinyama, Ken Ebihara and J. Paterson and has published in prestigious journals such as Science, Journal of Biological Chemistry and Circulation.

In The Last Decade

Hiroaki Masuzaki

236 papers receiving 12.4k citations

Hit Papers

A Transgenic Model of Vis... 1997 2026 2006 2016 2001 1997 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
    2001 1.4k citations Hiroaki Masuzaki, J. Paterson et al. profile →
  2. Nonadipose tissue production of leptin: Leptin as a novel placenta-derived hormone in humans
    1997 1.0k citations Hiroaki Masuzaki, Yoshihiro Ogawa et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroaki Masuzaki Japan 56 5.0k 4.6k 3.3k 3.0k 2.6k 243 12.8k
Christian Weyer United States 44 5.0k 1.0× 3.7k 0.8× 4.1k 1.2× 4.1k 1.4× 1.6k 0.6× 63 12.3k
Guenther Boden United States 59 6.3k 1.2× 1.7k 0.4× 4.1k 1.2× 4.1k 1.4× 1.3k 0.5× 164 14.9k
Susan K. Fried United States 61 7.2k 1.4× 2.3k 0.5× 5.9k 1.8× 2.0k 0.7× 1.2k 0.5× 132 14.4k
Mathias Faßhauer Germany 62 6.6k 1.3× 2.2k 0.5× 6.9k 2.1× 1.7k 0.6× 604 0.2× 206 14.6k
Madhur K. Sinha United States 34 6.8k 1.3× 7.8k 1.7× 6.4k 1.9× 2.0k 0.7× 3.8k 1.5× 69 14.0k
Mário J.A. Saad Brazil 51 3.9k 0.8× 2.0k 0.4× 2.4k 0.7× 1.7k 0.6× 1.0k 0.4× 183 10.0k
Uberto Pagotto Italy 59 3.0k 0.6× 2.1k 0.4× 1.4k 0.4× 5.2k 1.7× 783 0.3× 269 13.3k
Martin Haluzı́k Czechia 53 3.9k 0.8× 1.4k 0.3× 3.9k 1.2× 2.8k 0.9× 711 0.3× 363 12.1k
Yasuhiko Minokoshi Japan 46 6.0k 1.2× 4.3k 0.9× 4.1k 1.2× 1.6k 0.6× 1.6k 0.6× 96 12.8k
Maureen Charron United States 57 3.5k 0.7× 1.4k 0.3× 1.5k 0.5× 2.9k 1.0× 949 0.4× 166 11.1k

Countries citing papers authored by Hiroaki Masuzaki

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Masuzaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Masuzaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Masuzaki more than expected).

Fields of papers citing papers by Hiroaki Masuzaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Masuzaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Masuzaki. The network helps show where Hiroaki Masuzaki may publish in the future.

Co-authorship network of co-authors of Hiroaki Masuzaki

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Masuzaki. A scholar is included among the top collaborators of Hiroaki Masuzaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Masuzaki. Hiroaki Masuzaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Maimaituxun, Gulinu, Moritake Higa, Haruka Saito, et al.. (2024). Role of perirenal adiposity in renal dysfunction among CKD individuals with or without diabetes: a Japanese cross-sectional study. BMJ Open Diabetes Research & Care. 12(2). e003832–e003832. 5 indexed citations
3.
4.
Sato, Masahiro, Akimitsu Miyake, Yoshinori Shimajiri, et al.. (2024). Machine learning-based reproducible prediction of type 2 diabetes subtypes. Diabetologia. 67(11). 2446–2458. 8 indexed citations
5.
6.
Saito, Rumiko, Takashi Miyagi, Masaki Hayashi, et al.. (2021). Genetic profile of adult T‐cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV‐1 strains. Cancer Science. 112(3). 1300–1309. 16 indexed citations
7.
Masuzaki, Hiroaki, et al.. (2021). Novel strategies for glycaemic control and preventing diabetic complications applying the clustering-based classification of adult-onset diabetes mellitus: A perspective. Diabetes Research and Clinical Practice. 180. 109067–109067. 39 indexed citations
8.
Yamashita, Yoshiko, Naoki Imaizumi, Megumi Kato, et al.. (2020). Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL. Blood Advances. 4(6). 1062–1071. 14 indexed citations
9.
Karube, Kennosuke, Sawako Nakachi, Shiki Okamoto, et al.. (2019). Phosphorylated STAT3 expression predicts better prognosis in smoldering type of adult T‐cell leukemia/lymphoma. Cancer Science. 110(9). 2982–2991. 11 indexed citations
10.
Ogoshi, Takaaki, Masato Tsutsui, Takashi Kido, et al.. (2018). Protective Role of Myelocytic Nitric Oxide Synthases against Hypoxic Pulmonary Hypertension in Mice. American Journal of Respiratory and Critical Care Medicine. 198(2). 232–244. 15 indexed citations
11.
Kinjo, Takeshi, H Aoyama, Takeaki Tomoyose, et al.. (2015). Fatal pneumonia and viremia due to human parainfluenza virus type 1 in a patient with adult T-cell leukemia–lymphoma treated with mogamulizumab. Journal of Infection and Chemotherapy. 21(11). 820–823. 6 indexed citations
12.
Shimabukuro, Michio, et al.. (2011). Distinct effects of pitavastatin and atorvastatin on lipoprotein subclasses in patients with Type 2 diabetes mellitus. Diabetic Medicine. 28(7). 856–864. 12 indexed citations
13.
Lee, Yun Sok, Jin Woo Choi, Injae Hwang, et al.. (2010). Adipocytokine Orosomucoid Integrates Inflammatory and Metabolic Signals to Preserve Energy Homeostasis by Resolving Immoderate Inflammation. Journal of Biological Chemistry. 285(29). 22174–22185. 110 indexed citations
14.
Harada, Eisaku, Hirofumi Yasue, Yuji Mizuno, et al.. (2007). Metabolic Derangements in an Adult Patient With Tetralogy of Fallot: Possible Role of Chronic Systemic Hypoxia. The American Journal of the Medical Sciences. 334(4). 301–304. 2 indexed citations
15.
Masuzaki, Hiroaki, Hiroshi Yamamoto, Christopher J. Kenyon, et al.. (2003). Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. Journal of Clinical Investigation. 112(1). 83–90. 34 indexed citations
16.
Masuzaki, Hiroaki, Hiroshi Yamamoto, Christopher J. Kenyon, et al.. (2003). Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. Journal of Clinical Investigation. 112(1). 83–90. 345 indexed citations
17.
Morton, Nicholas M., J. Paterson, Hiroaki Masuzaki, et al.. (2003). Reduced intra-adipose glucocorticoid regeneration: A novel adaptive response to, and therapy for, the metabolic syndrome. 2 indexed citations
18.
Fukuda, Hiroko, Hiroaki Masuzaki, & Tetsuya Ishimaru. (2002). Interleukin‐6 and interleukin‐1 receptor antagonist in amniotic fluid and cord blood in patients with pre‐term, premature rupture of the membranes. International Journal of Gynecology & Obstetrics. 77(2). 123–129. 37 indexed citations
19.
Masuzaki, Hiroaki, et al.. (1996). Transvaginal color Doppler studies in gestational trophoblastic disease. Ultrasound in Obstetrics and Gynecology. 7(3). 197–200. 5 indexed citations
20.
Yoshimura, Satoshi, et al.. (1992). Comparison of eight different ultrasonographic parameters for predicting lethal fetal pulmonary hypoplasia. 19(3). 28–34. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Weyer Breakdown of academic impact, for papers by Guenther Boden Breakdown of academic impact, for papers by Susan K. Fried Breakdown of academic impact, for papers by Mathias Faßhauer Breakdown of academic impact, for papers by Madhur K. Sinha Breakdown of academic impact, for papers by Mário J.A. Saad Breakdown of academic impact, for papers by Uberto Pagotto Breakdown of academic impact, for papers by Martin Haluzı́k Breakdown of academic impact, for papers by Yasuhiko Minokoshi Breakdown of academic impact, for papers by Maureen Charron
Rankless by CCL
2026